🔎 Trials Near Me

Home › Burkitt Lymphoma › Texas › Austin

Burkitt Lymphoma clinical trials in Austin, TX

5 studies for Burkitt Lymphoma are looking for participants at sites in and around Austin (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

RecruitingPhase 2
  • Dell Children's Medical Center of Central Texas, Austin
Ages 1 to 30 · All sexes · Updated Sep 1, 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

RecruitingPhase 3
  • Dell Children's Medical Center of Central Texas, Austin
365 Days – 25 Years · All sexes · Updated Aug 25, 2026 · NCT03959085

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

RecruitingPhase 1/2
  • Sarah Cannon - St. David's South Austin Medical Center, Austin
Ages 15 to 50 · All sexes · Updated Sep 9, 2025 · NCT04150497

Burkitt Lymphoma trials in other cities

Other studies in Austin

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.